Menu Search
Equities

Diagnos Laboratorium Utama PT Tbk

DGNS:JKT

Diagnos Laboratorium Utama PT Tbk

Actions
Health CareMedical Equipment and Services
  • Price (IDR)340.00
  • Today's Change0.00 / 0.00%
  • Shares traded7.12m
  • 1 Year change+42.86%
  • Beta--
Data delayed at least 10 minutes, as of May 02 2024 10:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Diagnos Laboratorium Utama Tbk is an Indonesia-based company that is engaged in providing health services using laboratories. The Company’s scope of activities also includes private clinical activities. Its products and services include clinical pathology laboratory tests, anatomical pathology laboratory tests, genomics laboratory tests, homecare health tests, corporate health tests and Covid-19 tests. Its clinical pathology laboratory provides services ranging from molecular examinations to support more treatment. Its clinical pathology laboratory provides services for examination of hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology and microbiology. The services provided at the genetic laboratory are non-invasive prenatal testing (NIPT), preimplantation genetic testing for aneuploidy (PGT-A) services, and preimplantation genetic testing for monogenic diseases (PGT-M) services. Its homecare health services provide health checks that are done at home.

  • Revenue in IDR (TTM)145.70bn
  • Net income in IDR-13.66bn
  • Incorporated--
  • Employees64.00
  • Location
    Diagnos Laboratorium Utama PT TbkJakartalaboratoryJl. Teuku Cik Ditiro No.28 CentralJAKARTA IndonesiaIDN
  • Phone+62 213193183
  • Websitehttps://diagnos.co.id/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		DGNS:JKT since
announced		Transaction
value
Asa Ren Pte LtdAnnounced14 Mar 202414 Mar 2024Announced16.44%22.99m
Data delayed at least 10 minutes, as of May 02 2024 10:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.